KRAS G12C inhibitor 35 is a selective inhibitor targeting the KRAS G12C mutation, a driver mutation frequently associated with various cancers. This compound effectively disrupts KRAS signaling pathways, leading to inhibition of tumor cell proliferation. It serves as a valuable tool for research into KRAS G12C-mediated oncogenesis and therapeutic strategies in cancer treatment.
KRAS G12C inhibitor 35 is a selective inhibitor targeting the KRAS G12C mutation, a driver mutation frequently associated with various cancers. This compound effectively disrupts KRAS signaling pathways, leading to inhibition of tumor cell proliferation. It serves as a valuable tool for research into KRAS G12C-mediated oncogenesis and therapeutic strategies in cancer treatment.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
